[go: up one dir, main page]

GB201813065D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201813065D0
GB201813065D0 GBGB1813065.8A GB201813065A GB201813065D0 GB 201813065 D0 GB201813065 D0 GB 201813065D0 GB 201813065 A GB201813065 A GB 201813065A GB 201813065 D0 GB201813065 D0 GB 201813065D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1813065.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aritos Pharma Ltd
Original Assignee
Aritos Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aritos Pharma Ltd filed Critical Aritos Pharma Ltd
Priority to GBGB1813065.8A priority Critical patent/GB201813065D0/en
Publication of GB201813065D0 publication Critical patent/GB201813065D0/en
Priority to PCT/GB2019/052242 priority patent/WO2020030924A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1813065.8A 2018-08-10 2018-08-10 Novel compounds Ceased GB201813065D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1813065.8A GB201813065D0 (en) 2018-08-10 2018-08-10 Novel compounds
PCT/GB2019/052242 WO2020030924A1 (en) 2018-08-10 2019-08-09 Thiazoleureas as anticancer agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1813065.8A GB201813065D0 (en) 2018-08-10 2018-08-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB201813065D0 true GB201813065D0 (en) 2018-09-26

Family

ID=63667053

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1813065.8A Ceased GB201813065D0 (en) 2018-08-10 2018-08-10 Novel compounds

Country Status (2)

Country Link
GB (1) GB201813065D0 (en)
WO (1) WO2020030924A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202006254D0 (en) 2020-04-28 2020-06-10 Institute Of Cancer Res Anti-cancer vaccines and related therapy
KR20230154191A (en) * 2021-02-07 2023-11-07 아티오스 파마 리미티드 new method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645990B2 (en) * 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
US20020173507A1 (en) * 2000-08-15 2002-11-21 Vincent Santora Urea compounds and methods of uses
US10760081B2 (en) 2015-10-07 2020-09-01 New York University Compositions and methods for enhancing CRISPR activity by POLQ inhibition

Also Published As

Publication number Publication date
WO2020030924A1 (en) 2020-02-13
WO2020030924A4 (en) 2020-04-02

Similar Documents

Publication Publication Date Title
IL280767A (en) Novel sulfonamideurea compounds
SG11202010907VA (en) Novel compounds
IL279526A (en) Novel compounds
GB201819083D0 (en) Novel compounds
GB201803393D0 (en) Novel compounds
GB201803394D0 (en) Novel compounds
IL282096A (en) Novel compounds
GB201813060D0 (en) Novel compounds
GB201809378D0 (en) Novel compounds
GB201813065D0 (en) Novel compounds
GB201811165D0 (en) Novel compounds
GB201821000D0 (en) Novel compounds
GB201817921D0 (en) Novel compounds
GB201817616D0 (en) Novel compounds
GB201816543D0 (en) Novel compounds
GB201813281D0 (en) Novel compounds
GB201813285D0 (en) Novel compounds
GB201813280D0 (en) Novel compounds
GB201813284D0 (en) Novel compounds
GB201813283D0 (en) Novel compounds
GB201813198D0 (en) Novel compounds
GB201813049D0 (en) Novel Compounds
GB201812226D0 (en) Novel compounds
GB201812225D0 (en) Novel compounds
GB201810983D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)